sub:assertion {
  d:DB06779 v:identifier "DB06779" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB06779" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB06779> ;
    dv:drugbank-id "DB06779" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:20:12.04.16> ;
    dv:x-atc <http://bio2rdf.org/atc:B01AB04> ;
    dv:x-cas <http://bio2rdf.org/cas:9041-08-1> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D03353> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Dalteparin_sodium> ;
    dct:description "Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant. It is composed of strongly acidic sulphated polysaccharide chains with an average molecular weight of 5000 and about 90% of the material within the range of 2000-9000. LMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin."@en ;
    dct:identifier "drugbank:DB06779" ;
    dct:title "Dalteparin"@en ;
    a dv:Drug ;
    rdfs:label "Dalteparin [drugbank:DB06779]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB06779> .
}